FDA NDC Directory · JSON-LD · Markdown

Olanzapine

NDC 0527-3162 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerLannett Company, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA208146
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsOLANZAPINE (10 mg/1)
Marketing started20230530
Package count1

External sources

Source: openFDA. Public-domain (CC0).